Literature DB >> 25339249

Effects of American ginseng on pharmacokinetics of 5-fluorouracil in rats.

Yi-Sheng He1, Wei Sun, Chong-Zhi Wang, Lian-Wen Qi, Jie Yang, Ping Li, Xiao-Dong Wen, Chun-Su Yuan.   

Abstract

The pharmacokinetics of 5-fluorouracil (5-FU) in combination with or without American ginseng (seven-consecutive days oral dose) in rats were evaluated using liquid chromatography-electrospray ionization-mass spectrometry (LC-MS). Chromatographic separation was performed on a reverse LC column within a total run time of 6.5 min, which allowed for a relatively quick analysis. The limit of quantification for 5-FU was 15 ng/mL and this method was linear over 15-50,000 ng/mL. This method supported stabilizing determination of the plasma concentration of 5-FU over a period of 24 h. Precision both interday and intraday (coefficient of variation) was within 14% and accuracy (relative error) ranged from -5 to 14%. In view of the observed pharmacokinetic parameters, including maximum concentration, time to maximum concentration, area under the concentration-time curve (AUC), mean residence time, elimination half-life and clearance, our results showed no significant differences in all of the pharmacokinetic parameters between the ginseng co-treated group and 5-FU alone group. Some increase in AUC was observed in 5-FU plus ginseng group; however, the difference did not reach statistical significance compared with 5-FU alone. It appeared that American ginseng administration did not significantly alter the kinetics of 5-FU. More studies are still needed to confirm our results.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  5-fluorouracil; American ginseng; LC-MS; herb-drug interaction; pharmacokinetics

Mesh:

Substances:

Year:  2014        PMID: 25339249      PMCID: PMC4405504          DOI: 10.1002/bmc.3354

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  25 in total

1.  Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines.

Authors:  M Masuda; M Suzui; I B Weinstein
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

2.  Chemical and pharmacological studies of saponins with a focus on American ginseng.

Authors:  Chun-Su Yuan; Chong-Zhi Wang; Sheila M Wicks; Lian-Wen Qi
Journal:  J Ginseng Res       Date:  2010-09-01       Impact factor: 6.060

3.  Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro.

Authors:  Jinping Qiao; Chenxin Gu; Weihu Shang; Jinglei Du; Wei Yin; Meilin Zhu; Wei Wang; Mei Han; Weidong Lu
Journal:  Food Chem Toxicol       Date:  2011-03-31       Impact factor: 6.023

Review 4.  Drug interactions with phytotherapeutics in oncology.

Authors:  Walter Emil Haefeli; Alexandra Carls
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-01-06       Impact factor: 4.481

5.  LC-MS/MS method for simultaneous analysis of uracil, 5,6-dihydrouracil, 5-fluorouracil and 5-fluoro-5,6-dihydrouracil in human plasma for therapeutic drug monitoring and toxicity prediction in cancer patients.

Authors:  Barbara Büchel; Peter Rhyn; Stefan Schürch; Claudia Bühr; Ursula Amstutz; Carlo R Largiadèr
Journal:  Biomed Chromatogr       Date:  2012-03-27       Impact factor: 1.902

Review 6.  Isolation and analysis of ginseng: advances and challenges.

Authors:  Lian-Wen Qi; Chong-Zhi Wang; Chun-Su Yuan
Journal:  Nat Prod Rep       Date:  2011-01-24       Impact factor: 13.423

7.  Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells.

Authors:  Xiao-Li Li; Chong-Zhi Wang; Sangeeta R Mehendale; Shi Sun; Qi Wang; Chun-Su Yuan
Journal:  Cancer Chemother Pharmacol       Date:  2009-03-11       Impact factor: 3.333

Review 8.  Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy.

Authors:  Toshiyuki Sakaeda; Motohiro Yamamori; Akiko Kuwahara; Kohshi Nishiguchi
Journal:  Adv Drug Deliv Rev       Date:  2008-12-24       Impact factor: 15.470

9.  Development and utilization of a combined LC-UV and LC-MS/MS method for the simultaneous analysis of tegafur and 5-fluorouracil in human plasma to support a phase I clinical study of oral UFT®/leucovorin.

Authors:  Cody J Peer; Terence J McManus; Herbert I Hurwitz; William P Petros
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-04-20       Impact factor: 3.205

10.  Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 2.

Authors:  S M Sagar; D Yance; R K Wong
Journal:  Curr Oncol       Date:  2006-06       Impact factor: 3.677

View more
  4 in total

1.  Red American ginseng enhances the effect of fluorouracil on human colon cancer cells via both paraptosis and apoptosis pathways.

Authors:  Jin-Yi Wan; Haiqiang Yao; Chun-Feng Zhang; Wei-Hua Huang; Qihui Zhang; Zhi Liu; Yi Bi; Stephanie Williams; Chong-Zhi Wang; Chun-Su Yuan
Journal:  J Appl Biomed       Date:  2018-05-31       Impact factor: 1.797

2.  The Herb-Drug Pharmacokinetic Interaction of 5-Fluorouracil and Its Metabolite 5-Fluoro-5,6-Dihydrouracil with a Traditional Chinese Medicine in Rats.

Authors:  Ju-Han Liu; Yung-Yi Cheng; Chen-Hsi Hsieh; Tung-Hu Tsai
Journal:  Int J Mol Sci       Date:  2017-12-23       Impact factor: 5.923

Review 3.  American Ginseng (Panax quinquefolium L.) as a Source of Bioactive Phytochemicals with Pro-Health Properties.

Authors:  Daria Szczuka; Adriana Nowak; Małgorzata Zakłos-Szyda; Ewa Kochan; Grażyna Szymańska; Ilona Motyl; Janusz Blasiak
Journal:  Nutrients       Date:  2019-05-09       Impact factor: 5.717

4.  Evaluation of the Effects of Astragalus membranaceus on the Pharmacokinetics of Pemetrexed Disodium and Gemcitabine in Rats by a Simple High-Performance Liquid Chromatography/UV Method.

Authors:  Zixuan Chu; Zhiyuan Wang; Teng Liu; Shan Xiong; Bin Liu
Journal:  J Anal Methods Chem       Date:  2019-04-28       Impact factor: 2.193

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.